CORTICOSTEROID THERAPY AND SIDE EFFECTS INVOLVING THE SKIN

1972 ◽  
Vol 2 (22) ◽  
pp. 1220-1220
Keyword(s):  
Side Effects ◽  
Corticosteroid Therapy

The Use and Abuse of Topical Corticosteroids

1977 ◽  
Vol 63 (1) ◽  
pp. 18-25
Author(s):  
M. D. Catterall
Keyword(s):  
Side Effects ◽  
Topical Corticosteroid ◽  
Corticosteroid Therapy ◽  
Rank Order ◽  
Topical Corticosteroids ◽  
Systemic Side Effects

AbstractA rationalised approach to topical corticosteroid therapy is presented. Factors which influence the choice of preparation are considered, based upon the concept of ’rank order ’, for both halogenated and non-halogenated steroids. Practical considerations, including choice of base, polythene occlusion and tachyphylaxis are discussed and local and systemic side effects considered in detail.

Behavioral Side Effects of Corticosteroid Therapy

1993 ◽  
Vol 23 (12) ◽  
pp. 703-708 ◽  
Author(s):  
Victor I Reus ◽  
Owen M Wolkowitz
Keyword(s):  
Side Effects ◽  
Corticosteroid Therapy

A Comparison of the Efficacy, Relapse Rate and Side Effects among Three Modalities of Systemic Corticosteroid Therapy for Alopecia Areata

Dermatology ◽  
2006 ◽  
Vol 212 (4) ◽  
pp. 361-365 ◽  
Author(s):  
Masahiro Kurosawa ◽  
Satoshi Nakagawa ◽  
Masato Mizuashi ◽  
Yoshinori Sasaki ◽  
Maki Kawamura ◽  
...  
Keyword(s):  
Side Effects ◽  
Corticosteroid Therapy ◽  
Relapse Rate ◽  
Alopecia Areata ◽  
Systemic Corticosteroid ◽  
Systemic Corticosteroid Therapy

scholarly journals The Treatment of Autoimmune Hemolytic Anemia with 6-Mercaptopurine and Thioguanine

Blood ◽  
1962 ◽  
Vol 19 (4) ◽  
pp. 483-500 ◽  
Author(s):  
ROBERT S. SCHWARTZ ◽  
WILLIAM DAMESHEK
Keyword(s):  
Side Effects ◽  
Hemolytic Anemia ◽  
Corticosteroid Therapy ◽  
Autoimmune Hemolytic Anemia ◽  
Good Effect ◽  
Control Side ◽  
Degrees Of Severity

Abstract Fourteen patients with autoimmune hemolytic anemia were treated with either 6-mercaptopurine or thioguanine. Nine patients responded and five failed to improve. Eight patients developed side effects, either hematologic or gastrointestinal, of varying degrees of severity; in three the antimetabolite had to be discontinued, while in others adjustment of the dosage or the administration of antacids was sufficient to control side effects. Included in this series are nine patients who failed to respond adequately to corticosteroid therapy; four of these had a good effect from antimetabolite therapy. Although these results indicate that antimetabolites may reverse the course of autoimmune hemolytic anemia, the eventual role of these agents in the treatment of this disorder requires further study.

Progressive Diaphyseal Dysplasia: Evaluation of Corticosteroid Therapy

PEDIATRICS ◽  
1985 ◽  
Vol 75 (2) ◽  
pp. 321-323
Author(s):  
Yehezkel Naveh ◽  
Uri Alon ◽  
Joseph K. Kaftori ◽  
Moshe Berant
Keyword(s):  
Single Dose ◽  
Side Effects ◽  
Corticosteroid Therapy ◽  
Initial Dose ◽  
Maintenance Dose ◽  
Leg Pain ◽  
Low Doses ◽  
Poor Appetite ◽  
Progressive Diaphyseal Dysplasia ◽  
Diaphyseal Dysplasia

Progressive diaphyseal dysplasia is characterized clinically by crippling leg pain, fatigue, headache, poor appetite, muscle weakness, and waddling gait. Twelve affected patients, aged 2 years 4 months to 40 years, were treated with intermittent courses of low doses of prednisone given in a single dose on alternate mornings for periods ranging from 6 months to 10 years. The average initial dose of prednisone was 0.6 mg/kg/d, and average maintenance dose was 0.3 mg/kg/d. Relief of all crippling symptoms was achieved in all patients. No untoward serious side effects have been observed, and the growth of children was not slowed. However, corticosteroid therapy should be restricted to patients suffering from crippling pain. The mechanism through which steroids act remains undefined.

Sign in / Sign up

Export Citation Format

Share Document